| Income Statement | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Total other income (expense) | -1,042,281 | -2,200,379 | ||
| Net loss before income taxes | -2,895,585 | -4,093,231 | ||
| Income taxes | - | 0 | ||
| Net loss | -2,895,585 | -4,093,231 | ||
| Net loss per share basic (in dollars per share) | -0.05 | -0.12 | ||
| Net loss per share diluted (in dollars per share) | -0.05 | -0.12 | ||
| Weighted average common shares outstanding (in shares) | 59,416,539 | 33,952,418 | ||
| Weighted-average common shares outstanding, diluted | 59,416,539 | 33,952,418 | ||
Klotho Neurosciences, Inc. (KLTOW)
Klotho Neurosciences, Inc. (KLTOW)